Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.

House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, Todd KL, Henderson MA, Giuffrida L, Petley EV, Sek K, Mardiana S, Gide TN, Quek C, Scolyer RA, Long GV, Wilmott JS, Loi S, Darcy PK, Beavis PA.

Clin Cancer Res. 2020 Jan 15;26(2):487-504. doi: 10.1158/1078-0432.CCR-19-1868. Epub 2019 Oct 21.

2.

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells.

Beavis PA, Henderson MA, Giuffrida L, Davenport AJ, Petley EV, House IG, Lai J, Sek K, Milenkovski N, John LB, Mardiana S, Slaney CY, Trapani JA, Loi S, Kershaw MH, Haynes NM, Darcy PK.

Cancer Immunol Res. 2018 Sep;6(9):1069-1081. doi: 10.1158/2326-6066.CIR-18-0291. Epub 2018 Jul 17.

3.

Tumor-derived exosomes modulate T cell function through transfer of RNA.

House IG, Petley EV, Beavis PA.

FEBS J. 2018 Mar;285(6):1030-1032. doi: 10.1111/febs.14413.

4.

A novel combination strategy for effectively targeting cancer stem-like cells.

Beavis PA, Petley EV, Darcy PK.

Immunol Cell Biol. 2017 Aug;95(7):573-574. doi: 10.1038/icb.2017.39. Epub 2017 Jun 6. No abstract available.

PMID:
28529324

Supplemental Content

Loading ...
Support Center